News
WHO’s new global guidance helps clinicians manage dengue, Zika, chikungunya, and yellow fever with protocols for fluids, ...
11d
Newspoint on MSNPhase-3 clinical trial enrolment for India’s first dengue vaccine to be completed by October: ICMREnrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR
ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.
11monon MSN
After recovering from dengue fever, there are times when you experience prolonged fatigue, joint pain, hair loss, along with reduced immunity. These post-recovery symptoms can complicate the return to ...
The vaccine strain (TV003/TV005), originally developed by the US National Institutes of Health (NIH), has shown promising ...
A health alert has been issued for tourists traveling to Europe this summer as two potentially fatal diseases have been ...
3d
Inquirer on MSNTrial of new dengue vaccine begins recruitment for child participants in SingaporeThe new vaccine aims to provide protection against all four dengue serotypes. Read more at straitstimes.com. Read more at ...
Dengue fever hits record numbers. Can it be controlled? : Goats and Soda Case counts are skyrocketing in countries like Brazil and Peru and the virus is popping up in new turf, from Florida to Iran.
Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results